Pfizer announced that its vaccine developed by a German health startup has 90 percent efficacy.
Research house and brokerage Motilal Oswal has suggested BUY Call for pharmaceutical major Aurobindo Pharma with a target price of Rs 985.
Ace investor Rakesh Jhunjhunwala has raised his stake in Lupin during the last quarter. Pharmaceutical sector has witnessed strong performance after COVID-19 pandemic led to lockdowns.
Pharmaceutical major Wockhardt has signed a deal with the UK government to supply COVID-19 vaccine under development and testing by AstraZeneca and researchers from Oxford University.
Angel Broking has suggested two BUY Call for short term investors.
Market expert Sanjiv Bhasin has suggested five stocks for investors and medium-term outlook traders for August in the pharmaceutical segment.
© 2005-2020 TOPNEWS.IN ALL RIGHTS RESERVED. COPYSCAPE PROTECTED